Breast Cancer Profiling Project, Drug Sensitivity phase I: Fixed-cell GR measures of 35 breast cell lines to 34 small molecule perturbagens from library plate I. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20343)

Small Molecules Studied

HMS LINCS ID Name Alternative Names LINCS ID Structure Image PubChem CID
10445-1 Taselisib
GDC-0032; RG-7604
LSM-45140 51001932
10102-4 Taxol
Paclitaxel
LSM-1102 441276
10171-1 TGX221 LSM-1172 9907093
10131-1 Tivantinib
ARQ197
LSM-1131 11494412
10278-2 Topotecan
Hycamtin
LSM-5662 60700
10080-1 Torin2 LSM-1080 51358113
10142-1 Trametinib
GSK-1120212; GSK1120212; GSK1120212B; JTP-74057
LSM-1143 11707110
10387-1 Volasertib
BI6727
10461508
10282-2 Vorinostat
suberoylanilide hydroxamic acid (SAHA); Zolinza
LSM-3828 5311